Mrs Sarah J Schock, PHARM D - Pharmacist in Palmer, AK

Mrs Sarah J Schock, PHARM D is a Pharmacist based in Palmer, Alaska. Mrs Sarah J Schock is licensed to practice in Alaska (license number 1477) and her current practice location is 650 S Cobb St, Palmer, Alaska. She can be reached at her office (for appointments etc.) via phone at (907) 761-4233.

NPI number for Mrs Sarah J Schock is 1376817445 and her current mailing address is 16508 E Julie Marie Cir, Palmer, Alaska. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1376817445.

Contact Information

Mrs Sarah J Schock, PHARM D
650 S Cobb St,
Palmer, AK 99645-6320
(907) 761-4233
Not Available

Healthcare Provider's Profile

Full NameMrs Sarah J Schock
GenderFemale
SpecialityPharmacist
Location650 S Cobb St, Palmer, Alaska
Accepts Medicare AssignmentsDoes not participate in Medicare Program. She may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1376817445
  • Provider Enumeration Date: 03/06/2012
  • Last Update Date: 03/06/2012

Medical Identifiers

Medical identifiers for Mrs Sarah J Schock such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1376817445NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
183500000XPharmacist 1477 (Alaska)Primary
183500000XPharmacist 56512 (Washington)Secondary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mrs Sarah J Schock is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Mrs Sarah J Schock, PHARM D
16508 E Julie Marie Cir,
Palmer, AK 99645-7601

Ph: (907) 745-7443
Mrs Sarah J Schock, PHARM D
650 S Cobb St,
Palmer, AK 99645-6320

Ph: (907) 761-4233

News Archive

Shire receives Paragraph IV Notice Letter from Anchen over filing of ANDA for generic INTUNIV

Shire plc, the global specialty biopharmaceutical company, announces that it has received a Paragraph IV Notice Letter from Anchen Pharmaceuticals, Inc. advising of the filing of an Abbreviated New Drug Application for a generic version of Shire's 1 mg, 2 mg, 3 mg, and 4 mg guanfacine hydrochloride extended release tablets, INTUNIV(TM).

Two immunotherapies used together for the first time to fight against solid tumors

Two immunotherapies - one that enables the T-cells a patient already has to better attack a tumor and another that can produce an independent and vigorous immune response - are being given together for the first time to help more patients wage a stronger war on a wide range of solid tumors, researchers say.

New report: Population aging will have broad economic consequences for the U.S.

The aging of the U.S. population will have broad economic consequences for the country, particularly for federal programs that support the elderly, and its long-term effects on all generations will be mediated by how - and how quickly - the nation responds, says a new congressionally mandated report from the National Research Council.

Inherited variations in certain genes linked to toxicity of leukemia therapy

Investigators at St. Jude Children's Research Hospital have discovered inherited variations in certain genes that make children with acute lymphoblastic leukemia (ALL) susceptible to the toxic side effects caused by chemotherapy medications.

Workshop to address high-risk adolescent behaviors

The Evolution Institute and the University of Arizona's Frances McClelland Institute for Children, Youth, and Families are co-hosting an invitation-only workshop at the university, Oct. 30 - Nov. 2, for world-renowned scholars who will apply evolutionary theory to the development of practical solutions for high-risk adolescent behaviors plaguing Western societies.

Read more News

› Verified 9 days ago


Pharmacist in Palmer, AK

Kyla Elizabeth Newland, PHARMD.
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 650 S Cobb St, Palmer, AK 99645
Phone: 907-761-4233    
Ms. Eileen F Lawrence, RPH
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 1422 E Hidden Ranch Loop, Palmer, AK 99645
Phone: 907-745-6522    
Sean Patrick Curley, PHARMD
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 664 W Evergreen Ave, Palmer, AK 99645
Phone: 907-761-1460    
Katherine Fay Farrington, RPH
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 650 S Cobb St, Palmer, AK 99645
Phone: 907-761-4233    
Dr. Jacob Nathaniel Jordan, PHARMD
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 16455 E Maud Rd, Palmer, AK 99645
Phone: 541-817-2278    
Mr. Raymond Charles Grogan, RPH
Pharmacist
Medicare: Not Enrolled in Medicare
Practice Location: 650 S Cobb St, Palmer, AK 99645
Phone: 907-761-4233    Fax: 907-761-4227

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.